• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性下肢缺血溶栓治疗的当代趋势与结果

Contemporary trends and outcomes of thrombolytic therapy for acute lower extremity ischemia.

作者信息

Bath Jonathan, Kim Ryan J, Dombrovskiy Viktor Y, Vogel Todd R

机构信息

1 Division of Vascular Surgery, University of Missouri, School of Medicine, Columbia, USA.

2 Department of Surgery, Rutgers-Robert Wood Johnson Medical School, New Brunswick, USA.

出版信息

Vascular. 2019 Feb;27(1):71-77. doi: 10.1177/1708538118797782. Epub 2018 Sep 7.

DOI:10.1177/1708538118797782
PMID:30193552
Abstract

OBJECTIVE

Acute limb ischemia is a common vascular emergency requiring immediate intervention. Thrombolysis has been widely utilized for acute limb ischemia; the purpose of this study is to analyze contemporary trends, outcomes and complications of thrombolysis for acute limb ischemia.

METHODS

Patients were identified from the Nationwide Inpatient Sample (2003-2013) using ICD-9. Patients undergoing emergency thrombolysis for acute limb ischemia were evaluated. Three groups were analyzed: thrombolysis alone, thrombolysis and endovascular procedure (T+ENDO), and failed thrombolysis requiring open surgery (T+OPEN).

RESULTS

A total of 162,240 patients with acute limb ischemia were estimated: 33,615 patients (20.7%) underwent thrombolysis as the initial treatment. Mean age was 66.2 ± 34.9 years with 54% male. The utilization of thrombolysis increased significantly during the study period (16.8-24.2%, p < 0.0001). The most common group was thrombolysis and endovascular procedure (40.7%), followed by thrombolysis alone (34.1%), and T+OPEN (25.2%). Thrombolysis and endovascular procedure increased significantly over time (31.6-47.8%, p < 0.0001) whereas thrombolysis alone and T+OPEN significantly decreased (39.6-28.6% and 28.7-23.6%, respectively, p < 0.0001). Overall mortality was 4.9%; thrombolysis and endovascular procedure compared to thrombolysis alone and T-OPEN had a lower mortality rate (3.2% vs. 6.1% and 5.9%, p < 0001). The overall stroke rate was 1.9%; thrombolysis alone had the highest stroke rate (3.0%, p < 0.0001) with thrombolysis and endovascular procedure the lowest (1.2%) and T+OPEN 1.7%. The highest amputation rate was T+OPEN (11.6%, p < 0.001) compared to thrombolysis and endovascular procedure (5.1%) and thrombolysis alone (5.3%). T+OPEN had the highest incidence of cardiac (5.5%), respiratory (7.3%) and renal complications (12.5%), pneumonia (4.0%), and fasciotomy (16.8%) (all p < 0.0001).

CONCLUSION

Thrombolysis remains an effective treatment for acute limb ischemia with increased utilization over time. There was a significant increase in thrombolysis and endovascular procedure leading to improved outcomes. Thrombolysis alone carried the highest mortality and stroke rate, with T+OPEN associated with the highest amputation and complications. Although thrombolysis is effective, 25% of patients required an open procedure suggesting that patient selection for thrombolysis first instead of open surgery continues to be a clinical challenge.

摘要

目的

急性肢体缺血是一种常见的血管急症,需要立即进行干预。溶栓已广泛应用于急性肢体缺血;本研究的目的是分析急性肢体缺血溶栓治疗的当代趋势、疗效及并发症。

方法

利用国际疾病分类第九版(ICD-9)从全国住院患者样本(2003 - 2013年)中识别患者。对接受急性肢体缺血急诊溶栓治疗的患者进行评估。分析三组情况:单纯溶栓、溶栓联合血管内介入治疗(T+ENDO)以及溶栓失败后需行开放手术(T+OPEN)。

结果

估计共有162,240例急性肢体缺血患者:33,615例患者(20.7%)接受溶栓作为初始治疗。平均年龄为66.2±34.9岁,男性占54%。在研究期间,溶栓治疗的使用率显著增加(16.8% - 24.2%,p<0.0001)。最常见的组是溶栓联合血管内介入治疗(40.7%),其次是单纯溶栓(34.1%),以及T+OPEN组(25.2%)。溶栓联合血管内介入治疗随时间显著增加(31.6% - 47.8%,p<0.0001),而单纯溶栓和T+OPEN组显著下降(分别为39.6% - 28.6%和28.7% - 23.6%,p<0.0001)。总体死亡率为4.9%;与单纯溶栓和T - OPEN相比,溶栓联合血管内介入治疗的死亡率较低(3.2% vs. 6.1%和5.9%,p<0.0001)。总体卒中率为1.9%;单纯溶栓的卒中率最高(3.0%,p<0.0001),溶栓联合血管内介入治疗最低(1.2%),T+OPEN为1.7%。截肢率最高的是T+OPEN组(11.6%,p<0.001),相比之下溶栓联合血管内介入治疗为(5.1%),单纯溶栓为(5.3%)。T+OPEN组心脏(5.5%)、呼吸(7.3%)和肾脏并发症(12.5%)、肺炎(4.0%)以及筋膜切开术(16.8%)的发生率最高(均p<0.0001)。

结论

溶栓仍然是急性肢体缺血的有效治疗方法,且随着时间推移使用率增加。溶栓联合血管内介入治疗显著增加,从而改善了疗效。单纯溶栓的死亡率和卒中率最高,T+OPEN与最高的截肢率和并发症相关。尽管溶栓有效,但25%的患者需要进行开放手术,这表明选择首先进行溶栓而非开放手术的患者仍然是一项临床挑战。

相似文献

1
Contemporary trends and outcomes of thrombolytic therapy for acute lower extremity ischemia.急性下肢缺血溶栓治疗的当代趋势与结果
Vascular. 2019 Feb;27(1):71-77. doi: 10.1177/1708538118797782. Epub 2018 Sep 7.
2
Contemporary outcomes of endovascular interventions for acute limb ischemia.急性肢体缺血血管内介入治疗的当代疗效
J Vasc Surg. 2014 Apr;59(4):988-95. doi: 10.1016/j.jvs.2013.10.054. Epub 2013 Dec 17.
3
Acute Compartment Syndrome Following Thrombolysis For Acute Lower Limb Ischemia.急性下肢缺血溶栓治疗后急性骨筋膜室综合征
Ann Vasc Surg. 2022 Feb;79:182-190. doi: 10.1016/j.avsg.2021.07.015. Epub 2021 Oct 10.
4
Mid-Term Outcomes of Thrombolysis for Acute Lower Extremity Ischemia at a Tertiary Care Center.三级医疗中心急性下肢缺血溶栓治疗的中期结果
Ann Vasc Surg. 2020 Nov;69:317-323. doi: 10.1016/j.avsg.2020.05.050. Epub 2020 Jun 2.
5
Percutaneous isolated pharmaco-mechanical thrombolysis-thrombectomy system for the management of acute arterial limb ischemia: 30-day results from a single-center experience.经皮孤立的药物机械溶栓-血栓切除术系统治疗急性肢体动脉缺血:单中心经验的 30 天结果。
Catheter Cardiovasc Interv. 2012 Oct 1;80(4):636-43. doi: 10.1002/ccd.24283. Epub 2012 Apr 17.
6
Risk Factors for Long-Term Mortality and Amputation after Open and Endovascular Treatment of Acute Limb Ischemia.急性肢体缺血开放手术与血管腔内治疗后长期死亡率及截肢的危险因素
Ann Vasc Surg. 2016 Jan;30:82-92. doi: 10.1016/j.avsg.2015.10.004. Epub 2015 Nov 10.
7
Long-term prognostic factors after thrombolysis for lower limb ischemia.下肢缺血溶栓后的长期预后因素。
J Vasc Surg. 2008 Jun;47(6):1243-50. doi: 10.1016/j.jvs.2008.01.053.
8
Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia.血管内与手术血运重建治疗急性下肢缺血的疗效比较。
J Vasc Surg. 2015 Jan;61(1):147-54. doi: 10.1016/j.jvs.2014.06.109. Epub 2014 Jul 28.
9
Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.血液透析患者下肢血运重建术后住院结局和利用的全国趋势。
JACC Cardiovasc Interv. 2017 Oct 23;10(20):2101-2110. doi: 10.1016/j.jcin.2017.05.050.
10
Independent factors predicting early lower limb intra-arterial thrombolysis failure.预测早期下肢动脉内溶栓失败的独立因素。
Ann Vasc Surg. 2014 Jan;28(1):164-9. doi: 10.1016/j.avsg.2012.11.016. Epub 2013 Sep 5.

引用本文的文献

1
Brachial thromboembolectomy and retrograde innominate artery stenting in acute limb ischemia.急性肢体缺血的肱动脉血栓切除术及无名动脉逆行支架置入术
J Vasc Surg Cases Innov Tech. 2024 Nov 8;11(1):101675. doi: 10.1016/j.jvscit.2024.101675. eCollection 2025 Feb.
2
Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.用于严重肢体缺血细胞治疗的小鼠骨髓间充质干细胞与脂肪组织间充质干细胞的比较分析
Stem Cell Res Ther. 2021 Jan 13;12(1):58. doi: 10.1186/s13287-020-02110-x.
3
Acute Limb Ischemia: An Update on Diagnosis and Management.
急性肢体缺血:诊断与治疗的最新进展
J Clin Med. 2019 Aug 14;8(8):1215. doi: 10.3390/jcm8081215.